REGN vs USBC
Regeneron Pharmaceuticals Inc (REGN) versus US BioTec Inc (USBC) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
US BioTec Inc (USBC) is a agricultural inputs company listed on US.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported USBC revenue for 2023-09-30 was $0. Net income was -$15.3M. Revenue was down 100.0% from 2022-09-30 to 2023-09-30. USBC currently screens at market cap $0.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. USBC currently screens at market cap $0.
Not investment advice. Open the REGN and USBC stock pages for the full models.
Not investment advice.